Modified cyclic nucleotide gated ion channels

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S320100, C435S325000, C435S069100, C435S007200, C530S350000, C536S023500

Reexamination Certificate

active

07341836

ABSTRACT:
The present invention provides modified cyclic nucleotide gated (CNG) channels. In particularly preferred embodiments, the modified CNG channels exhibit increased sensitivity and specificity for cAMP, as compared to wild-type CNG channels. In additional embodiments, regulation by Ca2+-calmodulin has been removed in the modified CNG channels. Convenient optical methods for detecting changes in cAMP, taking advantage of the Ca2+permeability of the channel are also provided by the present invention. In addition, electrophysiological methods are further provided.

REFERENCES:
patent: 5312928 (1994-05-01), Goldin et al.
patent: 6183974 (2001-02-01), Bringhurst et al.
patent: 7052857 (2006-05-01), Zoller et al.
patent: 7115377 (2006-10-01), Yao et al.
patent: 2003/0100059 (2003-05-01), Yao et al.
patent: 2255548 (2000-06-01), None
patent: WO 98/58074 (1998-12-01), None
patent: WO 99/25384 (1999-05-01), None
patent: WO 99/35255 (1999-07-01), None
patent: WO 00/71565 (2000-11-01), None
Adams et al., “Fluorescence ratio imaging of cyclic AMP in single cells,”Nature, 349:694-697 [1991].
Ahluawalia and Rhoads, “Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction,”Biochem. Pharmacol., 31:665-669 [1982].
Ahn et al., “Effects of selective inhibitors on cyclic nucleotide phospho-diesterases of rabbit aorta,”Biochem. Pharmacol., 38:3331-3339 [1989].
Akita and Kuba, “Functional triads consisting of ryanodine receptors, Ca2+channels, and Ca2+-activated K+channels in bullfrog sympathetic neurons,”J. Gen. Physiol., 116:697-720 [2000].
Alvarez et al., “Regulation of cyclic AMP metabolism in human platelets: Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins,”Mol. Pharmacol., 20:302-309 [1981].
Bacskai et al., Spatially resolved dynamics of cAMP and protein kinase A subunits inAplysiasensory neurons,Science, 260:222-226 [1993].
Baylor et al., “The membrane current of single rod outer segments,”J. Physiol., 288:589-611 [1979].
Beavo, “Multiple isozymes of cyclic nucleotide phosphodiesterase,”Adv. Second Messenger Phosphoprot. Res., 22:1-38 [1988].
Beavo, “Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms,”Physiol. Rev., 75:725-748 [1995].
Bolger et al., “Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene,”Biochem. J., 328:539-548 [1997].
Bolger et al., “A family of human phosphodiesterases homologous to theduncelearning and memory gene product ofDrosophila melanogasterare potential targets for antidepressant drugs,”Mol. Cell. Biol., 13:6558-6571 [1993].
Boshart et al., “A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus,”Cell, 41:521-530 [1985].
Bridge et al., “The relationship between charge movements associated withICaandINa-Cain cardiac myocytes,”Science, 248:376-378 [1990].
Broillet, “A single intracellular cysteine residue is responsible for the activation of the olfactory cyclic nucleotide-gate channel by NO,”J. Biol. Chem., 275:15135-15141 [2000].
Brooker, “Oscillation of cyclic adenosine monophosphate concentration during the myocardial contraction cycle,”Science, 182:933-934 [1973].
Chen et al., “Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1,”Nature, 403:557-560 [2000].
Chen-Izu et al., “Gi-dependent localization of β2-adrenergic receptor signaling to L-type Ca2+channels,”Biophys. J., 79:2547-2556 [2000].
Conti et al., “Recent progress in understanding the hormonal regulation of phosphodiesterases,”Endocrine Res., 16:370-389 [1995].
Cooper et al., “Ca2+-sensitive adenylyl cyclases,”Adv. Second Messenger Phosphoprotein Res., 32:23-51 [1998].
Cooper et al., “Adenylyl cyclases and the interaction between calcium and cAMP signalling,”Nature. 374:421-424 [1995].
Coste and Grondin, “Characterization of a novel potent and specific inhibitor of type V phosphodiesterase,”Biochem. Pharmacol., 50:1577-1585 [1995].
Davare et al., “A β2adrenergic receptor signaling complex assembled with the Ca2+channel Cav1.2,”Science, 293:98-101 [2001].
Dhallan et al., “Primary structure and functional expression of a cyclic nucleotide-activated channel from olfactory neurons,”Nature, 347:184-187 [1990].
Dijkema, et al., “Cloning and expression of the chromosomal immune interferon gene of the rat,”EMBO J., 4:761-767 [1985].
Drummond and Perrot-Yee, “Enzymatic hydrolysis of adenosine 3′,5′-phosphoric acid,”J. Biol. Chem., 236:1126-1129 [1961].
Epstein et al., “Catalytic and kinetic properties of purified high-affinity cyclic AMP phosphodiesterase from dog kidney,”Arch. Biochem. Biophys., 218:119-133 [1982].
Evans et al., “Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms,”Mol. Pharmacol., 26:395-404 [1984].
Fagan et al., “Adenovirus encoded cyclic nucleotide-gated channels: A new methodology for monitoring cAMP in living cells,”FEBS Lett., 500:85-90 [2001].
Fagan et al., “Functional co-localization of transfected Ca2+-stimulable adenylyl cyclases with capacitative Ca2+entry sites,”J. Biol. Chem., 271:12438-12444 [1996].
Fagan et al., “Adenovirus-mediated expression of an olfactory cyclic nucleotide-gated channel regulates the endogenous Ca2+-inhibitable adenylyl cyclase in C6-2B glioma cells,”J. Biol. Chem., 274:12445-12453 [1999].
Fagan et al., “Regulation of a Ca2+-sensitive adenylyl cyclase in an excitable cell,”J. Biol. Chem., 275:40187-40194 [2000].
Fawcett et al., “Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A,”Proc. Natl. Acad. Sci. USA97:3702-3707 [2000].
Feliciello et al., “The biological functions of A-kinase anchor proteins,”J. Mol. Biol., 308:99-114 [2001].
Finch and Augustine, “Local calcium signalling by inositol-1,4,5-triphosphate in Purkinje cell dendrites,”Nature, 396:753-756 [1998].
Finn et al., “Cyclic nucleotide-gated ion channels: an extended family with diverse functions,”Ann. Rev. Physiol., 58:395-426 [1996].
Fisher et al., “Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase,”J. Biol. Chem., 273:15559-15564 [1998].
Francis and Corbin, “Cyclic nucleotide-dependent protein kinases: Intracellular receptors for cAMP and cGMP action,”Crit. Rev. Clin. Lab. Sci., 36:275-328 [1999].
Frings et al., “Profoundly different calcium permeation and blockage determine the specific function of distinct cyclic nucleotide-gated channels,”Neuron, 15:169-179 [1995].
Fung et al., “Flow of information in the light-triggered cyclic nucleotide cascade of vision,”Proc. Natl. Acad. Sci. USA, 78:152-156 [1981].
Gardner et al., “Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase,”Biochem. Biophys. Res. Commun., 272:186-192 [2000].
Gautvik et al., “Relationship between stimulated prolactin release from GH cells and cyclic AMP degradation and formation,”Mol. Cell. Endocrinol., 26:295-308 [1982].
Gómez-Foix et al., “Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism,”J. Biol. Chem., 267:25129-25134 [1992].
Gorczyca et al., “Purification and physiological evaluation of a guanylate cyclase activating protein from retinal rods,”Proc. Natl. Acad. Sci. USA, 91:4014-4018 [1994].
Gorman et al., “The Rous sarcoma virus l

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Modified cyclic nucleotide gated ion channels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified cyclic nucleotide gated ion channels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified cyclic nucleotide gated ion channels will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3979824

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.